Zevra Therapeutics, Inc. (ZVRA)
9.23
-0.17
(-1.81%)
USD |
NASDAQ |
Mar 20, 16:00
9.24
+0.01
(+0.11%)
After-Hours: 20:00
Zevra Therapeutics EPS Diluted (Quarterly) : 0.1969 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Stereotaxis, Inc. | -0.061 |
| Ironwood Pharmaceuticals, Inc. | -0.014 |
| Verastem, Inc. | -0.3947 |
| ADMA Biologics, Inc. | 0.2025 |
| Myomo, Inc. | -0.0904 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.83M |
| Revenue (Quarterly) | 34.12M |
| Total Expenses (Quarterly) | 22.30M |
| Enterprise Value | 414.10M |
| Gross Profit Margin (Quarterly) | 94.48% |
| Profit Margin (Quarterly) | 34.67% |
| Earnings Yield | 16.18% |
| Normalized Earnings Yield | 24.01 |